News

EpiCept intends to use the net proceeds it receives to meet its working capital needs and general corporate purposes through July 2008 and to pay certain fees owed

The notification was made in response to the company’s submission of a complete response to a prior notice from the FDA that had placed the drug on ‘clinical

In connection with this offering, Sequenom plans to grant to the underwriters a 30-day option to purchase up to an additional 825,000 shares of common stock. All of

Ta4 is a synthetic version of a biologically active, naturally occurring peptide that has been shown, in preclinical studies, to be effective in accelerating dermal, ophthalmic, and myocardial

The scientific collaboration is aimed at demonstrating the power and versatility of the Helicos true single molecule sequencing technology to measure the DNA sequence, methylation state, and mRNA

The collaboration includes a transfer of Boehringer Ingelheim technology to Geneart for the production and purification of plasmid DNA. The two partner companies also plan to closely collaborate

In addition to positive safety data and the good adsorption after oral administration, a first indication of biological activity of RhuDex was observed. The data obtained in the

The agreement will enhance selling efforts for Hill-Rom’s product, The Vest Airway Clearance system, to both acute and long-term care facilities within the US. Hill-Rom’s Vest system uses

BodyTel’s new partner, Diabetes Supplies, intends to begin offering BodyTel’s blood glucose monitoring and diabetes management system, GlucoTel, in New Zealand. Pursuant to the terms of the distribution